Navigation Links
JNCI news brief: STD confirmed to be associated with increased risk of prostate cancer
Date:9/9/2009

Researchers confirmed previous findings that the sexual transmitted infection known as Trichomonas vaginalis is associated with an increased risk of prostate cancer in a study published online September 9 in the Journal of the National Cancer Institute.

Jennifer Rider Stark, ScD, of the department of epidemiology at the Harvard School of Public Health in Boston, and colleagues conducted a case-control study nested within the Physicians' Health Study that included 673 case subjects with prostate cancer and 673 individually matched control subjects. Plasma was assayed for antibodies against T. vaginalis. The relationship of incident prostate cancer, extraprostatic prostate cancer, and cancer predicted to progress to bony metastases or prostate cancerspecific death was investigated.

Although not statistically significant, the size of the association between T. vaginalisseropositive status and overall prostate cancer risk was similar to that reported previously. A seropositive status was associated with statistically significantly increased risks of extraprostatic prostate cancer and cancer that is likely to progress to bony metastases or prostate cancerspecific death.

"If our findings are confirmed, T. vaginalis could serve as a marker for adverse outcomes in patients for prostate cancer or, more optimistically as a target for secondary chemoprevention," the authors write.

In an accompanying editorial, Peter C. Albertsen, M.D., of the University of Connecticut Health Center, in Farmington, Conn., said that this study is another example of assessing a specific variable to determine the risk of prostate cancer that deserves serious attention.

"Unfortunately, an unintended consequence of prostate-antigen testing is the large number of men diagnosed with incidental disease that now confounds our ability to identify potential causes of clinically significant disease," writes the editorialist, who also pointed out that a much larger study would be required to detect a statistically significant difference between seropositivity and overall prostate cancer risk.


'/>"/>

Contact: Steve Graff
jncimedia@oxfordjournals.org
301-841-1285
Journal of the National Cancer Institute
Source:Eurekalert

Related medicine news :

1. JNCI news brief: Melanosome dynamics and sensitivity of melanoma cells to chemotherapy
2. JNCI news brief: Surgeon training found effective in breast cancer sentinel lymph node trial
3. JNCI news brief: High serum insulin levels and risk of prostate cancer
4. JNCI news brief: Antibody linked to chemotherapy drug inhibits ovarian cancer in lab
5. JNCI news brief: Breast cancer hormone receptor status and risk of a second primary tumor
6. JNCI news brief: Hepatitis B virus mutations may predict risk of liver cancer
7. JNCI news brief: Improving the biomarker pipeline for early cancer detection
8. In brief: New prognostic indicator for patients with IPF
9. Asymchem Announces Fall Process Symposium Confirmed List of Speakers
10. Medifast Independent Director Lt. Gen. Dennis McCarthy Confirmed as Assistant Secretary of Defense for Reserve Affairs
11. Link between migraines and reduced breast cancer risk confirmed in follow-up study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... ... March 24, 2017 , ... Mlynarek Insurance ... to families and business owners across eastern Michigan, is connecting with the Oxford/Orion ... with financial difficulties. , The Oxford/Orion FISH Food Pantry works to ensure homeless, ...
(Date:3/24/2017)... Pittsburgh, PA (PRWEB) , ... March 24, 2017 ... ... the Oncology Nursing Society (ONS) wanted to create a communications platform that positions ... realize this goal, Elliance and ONS reinvented their online publication as an always-on, ...
(Date:3/24/2017)... ... 2017 , ... The law firm of Enea, Scanlan & Sirignano, LLP, ... resident Lauren C. Enea has joined the firm as an associate attorney. Ms. Enea, ... in elder law, Medicaid planning and applications, and Wills, Trusts and Estates. Samantha ...
(Date:3/24/2017)... , ... March 24, 2017 , ... ... year of enhancements, upgrading their training and leads programs. , In February, 2017, ... for elite sales agents, Performance Partners is designed to teach how to maximize ...
(Date:3/24/2017)... ... ... “End Time GPS”: a dauntless and enlightened study of the second-coming ... the creation of published author, Wesley Gerboth, a World War II veteran, with a ... Now, at age ninety-one, he shares the Wisdom God bestowed upon him in this ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... Oregon and PUNE, India , March 24, 2017 /PRNewswire/ ... 2015, and is estimated to reach $2,614 million by 2022, Globally, registering a CAGR ... to generate the highest revenue, and is projected to dominate the market during the ... ... Allied Market Research Logo ...
(Date:3/24/2017)... , March 24, 2017  Zymo Research ... and Hamilton Robotics, Inc., who designs, manufactures ... ongoing collaboration that teams Zymo Research,s DNA ... and DNA extraction products with Hamilton,s high-throughput ... optimized methods for microbiomics and RNA isolation ...
(Date:3/24/2017)... Research and Markets has announced the addition of the "Dental Implants ... ... for Dental Implants in US$ Million. The report provides separate comprehensive analytics ... , Europe , Asia-Pacific , ... Annual estimates and forecasts are provided for the period 2015 through 2022. ...
Breaking Medicine Technology: